The Pneumonia Testing Market size was valued at USD 2.11 Bn. in 2023 and the total Pneumonia Treatment revenue is expected to grow at a CAGR of 7.6% from 2024 to 2030, reaching nearly USD 3.5 Bn. in 2030.
Pneumonia Testing Market Overview:
Pneumonia is an inflammatory lung disease that mostly affects the alveoli, which are tiny air sacs. Most often, infections with bacteria or viruses cause pneumonia; infections with other microorganisms are less prevalent. It is challenging to determine which pathogen is at fault. A physical examination and symptoms are frequently used to make a diagnosis.
Click Here to Request a Sample:
Pneumonia testing market scope:
One of the main forces propelling the market is the growing healthcare sector. Due to their greater susceptibility to respiratory diseases, particularly pneumonia, older individuals require more precise testing protocols. Furthermore, the demographic component emphasizes the need for early detection and the market's obligation to cater to the particular healthcare requirements of the aging population.
Pneumonia testing segmentation:
By Type
Streptococcus
Legionella
Chlamydophila
Viral Pneumonia
Mycoplasma Pneumonia
By Methods
Molecular Diagnostics
Point-of-care testing
Immunodiagnostics
By End Users
Hospitals & Clinics
Diagnostic Laboratories
Homecare
Pneumonia Testing: Key Players:
The competitive landscape of the pneumonia testing market provides information about competitors.
1. Thermo Fisher Scientific Inc.
2. Abbott Laboratories
3. F-Hoffmann la Roche Ltd.
4. Hologic Inc.
5. BioMerieux
6. Becton
7. Dickenson and Company
8. Bio-Rad Laboratories Inc.
9. Meridian Biosciences
10. Quest Diagnostics, and Quidel.
11. AdvanDx
12. Beckman Coulter
13. Cepheid
14. Concile
15. Diamedix
16. DiaSorin
17. Fast-track Diagnostics
18. SeraCare
19. Trinity Biotech
Click here to learn more about the report:
Pneumonia Testing: Regional Analysis:
North America: Mexico, Canada, and the United States
Europe (including Austria, Sweden, Germany, Italy, Spain, UK, and France)
Asia Pacific includes Bangladesh, Pakistan, Taiwan, Malaysia, Vietnam, South Korea, Japan, India, Australia, Indonesia, and the rest of APAC.
Middle East and Africa (Egypt, Nigeria, Egypt, South Africa, and the GCC)
South America (including Argentina and Brazil)
More related reports:
Diesel Generator Market
lithium mining Market
Global Safety Switch Market
COVID-19 Impact Analysis on the Market:
The impact of COVID-19 on the pneumonia testing market is thoroughly examined in this paper. The COVID-19 pandemic has resulted in thousands of cases being recorded worldwide, prompting the World Health Organization to declare a global health emergency. There are ramifications for the pneumonia testing market from the coronavirus sickness that affected these individuals.
Key questions answered in the Pneumonia Testing Market Report are:
Which are the crucial factors aiding pneumonia testing market growth?
Which region has the largest share of the pneumonia testing market?
What will be the CAGR of the pneumonia testing market during the forecast period (2024–2030)?
Which segment emerged as the leading segment in the pneumonia testing market?
Who are the main players in the Pneumonia Testing market?
About Us
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries, such as IT & telecom, chemicals, food & beverage, aerospace & defense, healthcare, and others.
Our Address
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune-Banglore Highway, Narhe
Pune, Maharashtra, 411041, India.
✆ +91 9607365656
? sales@maximizemarketresearch.com
? www.maximizemarketresearch.com
Comments (0)